腹主动脉瘤腔内治疗中困难入路动脉的多中心回顾性研究
该多中心回顾性研究纳入76例2020年1月至2022年12月间因入路动脉狭窄或迂曲而使用低剖面覆膜支架行腹主动脉瘤腔内修复术的患者,平均随访28.1±9.0个月,技术成功率为96.1%,4例(5.2%)因支架闭塞再干预,8例(10.5%)随访期间发生II型内漏且未干预而消失,动脉瘤囊缩小25例(32.9%)、稳定51例(67.1%),总生存率98.7%。作者认为低剖面覆膜支架在观察期内安全有效。
要点
- 76例困难入路腹主动脉瘤患者使用低剖面覆膜支架行EVAR,技术成功率96.1%。
- 随访期间4例(5.2%)因支架闭塞再干预,8例(10.5%)II型内漏未干预而消失。
- 动脉瘤囊缩小25例(32.9%)、稳定51例(67.1%),总生存率98.7%。
核心结论
- 作者认为,在观察期内使用低剖面覆膜支架与安全性和有效性相关。
研究设计与样本
- 多中心回顾性研究,纳入3家三级医疗中心2020年1月至2022年12月间因入路动脉狭窄或迂曲而接受低剖面覆膜支架EVAR的76例患者。
主要发现
- 平均随访28.1±9.0个月(范围14.0-54.0个月)。
- 32例(42.1%)入路动脉狭窄(直径≤6.0 mm),29例(38.2%)入路动脉迂曲,15例(19.7%)同时存在狭窄和迂曲。
- 技术成功73例(96.1%),4例(5.2%)因支架闭塞再干预。
- 随访期间8例(10.5%)发生II型内漏,未干预,内漏在随访期间消失。
- 动脉瘤囊缩小25例(32.9%),稳定51例(67.1%),总生存率98.7%;狭窄组、迂曲组及狭窄合并迂曲组围手术期和随访结果比较均无统计学显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study is to document our experience using low-profile endografts for the endovascular repair of abdominal aortic aneurysms (AAAs) in cases where access arteries are challenging, commonly referred to as hostile access arteries. METHODS: Data regarding patients with narrow or tortuous access arteries who underwent endovascular aortic repair (EVAR) using low-profile endografts at 3 tertiary medical centers between January 2020 and December 2022 were retrospectively collected and analyzed. A total of 76 patients were enrolled in the study. The primary endpoints included technical success, occurrence of endoleaks, endograft occlusion, and any device- or procedure-related major adverse events. Secondary endpoints were assessed for endograft migration, endograft fracture, access site complications, and aneurismal sac shrinkage. RESULTS: The mean follow-up duration was 28.1 ± 9.0 months (range, 14.0-54.0). Among the patients, 32 (42.1%) had narrow artery access (diameter ≤6.0 mm), 29 (38.2%) had access arteries characterized by tortuosity, and 15 (19.7%) patients presented with both narrow and tortuous access arteries. Technical success was achieved in 73 (96.1%) cases. A total of 4 (5.2%) patients received reintervention due to endograft occlusion. During follow-up, a total of 8 (10.5%) type II endoleaks were observed during follow-up without intervention, and the endoleak disappeared in the follow-up period. Abdominal aortic aneurysm-sac shrinkage and stability were observed in 25 (32.9%) and 51 (67.1%) cases, respectively. The overall survival rate was 98.7%. The perioperative and follow-up outcomes for the groups categorized by 'Narrow arteries', 'Tortuous arteries', and 'Narrow and Tortuous arteries' did not show statistically significant differences when compared to each other. CONCLUSIONS: This preliminary investigation indicates that the use of low-profile endografts is associated with safety and effectiveness within the observed period.
引用
- Tang X, Feng J, Li Y, et al. Endovascular Treatment of Abdominal Aortic Aneurysm with Hostile Artery Access: A Multi-Center Retrospective Study. Ann Vasc Surg. 2024. PMID: 39580025. doi:10.1016/j.avsg.2024.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。